New deal looks good for the 2022 figures with NuvaRing and E4 hopefully both licensed by the FDA.
Mithra looks a very dynamic small European pharma focussed on developing new woman health drugs.
The Mithra September 19 Investors Slides show the estimated US FDA timing on both NuvaRing and E4. The Mithra slides show MYX's role in NuvaRing but have not been updated for the E4 deal with MYX. However the slides explain the massive advance that E4 has made and it is great for MYX with a 20 year license in the US market.
Maybe they should merge Mithra and MYX to make a small powerhouse.
- Forums
- ASX - By Stock
- Congratulations Mithra
New deal looks good for the 2022 figures with NuvaRing and E4...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.34 |
Change
0.080(1.88%) |
Mkt cap ! $369.2M |
Open | High | Low | Value | Volume |
$4.27 | $4.35 | $4.25 | $408.4K | 94.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1900 | $4.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.35 | 579 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1900 | 4.320 |
1 | 145 | 4.310 |
2 | 579 | 4.300 |
2 | 10145 | 4.290 |
2 | 579 | 4.280 |
Price($) | Vol. | No. |
---|---|---|
4.350 | 579 | 2 |
4.360 | 575 | 2 |
4.370 | 575 | 2 |
4.380 | 141 | 1 |
4.390 | 141 | 1 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online